Citizens JMP Downgrades Blueprint Medicines (BPMC) to Market Perform
On June 3, Citizens JMP analyst Reni Benjamin downgraded Blueprint Medicines Corporation (NASDAQ:BPMC) to Market Perform from Outperform without a price target.
Posts Tagged ‘NASDAQ:BPMC’
Stephens & Co. Downgrades Blueprint Medicines (BPMC) to Equal Weight, Cuts PT
On June 3, Stephens & Co.
Blueprint Medicines Corporation (BPMC) Downgraded at TD Cowen
This modification comes after Sanofi declared its intention to buy Blueprint Medicines Corporation (NASDAQ:BPMC).
Wolfe Research Lowered Blueprint Medicines Corporation (BPMC) from Outperform to Peer Perform
This happened after Sanofi announced plans to buy the company for $9.1 billion in stock value and up to $9.5 billion in contingent value rights.
Why Blueprint Medicines Corporation (BPMC) Skyrocketed On Monday
We recently published a list of These 10 Stocks Blew Past Expectations.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2025 Earnings Call Transcript
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2025 Earnings Call Transcript May 1, 2025Blueprint Medicines Corporation misses on earnings expectations.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call Transcript
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call Transcript February 13, 2025Blueprint Medicines Corporation misses on earnings expectations.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Nadia, and I'll be your conference operator today.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2024 Earnings Call Transcript
Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2024 Earnings Call Transcript August 1, 2024Blueprint Medicines Corporation beats earnings expectations.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $ EPS, expectations were $-1.64.
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript
Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-1.82, expectations were $-2.04.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript
Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-1.82, expectations were $-2.04.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
5 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
In this article, we discuss the 5 stocks receiving a massive vote of approval from Wall Street analysts.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Elliot and I will be your conference operator today.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. My name is Glen. I'll be your conference operator today.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2023 Earnings Call Transcript
Operator: Good morning. My name is Kelly. And I'll be your conference operator today.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the Blueprint Medicines Conference Call. At this time, all participants are in listen-only-mode.
13 Best Genomics Stocks To Buy Now
Before talking about the best genomics stocks, it is important to understand what the term actually means.
Ken Fisher Super Stocks: 10 Biggest Small-Cap Stocks
In this article, we discuss the 10 biggest small-cap stocks in the Ken Fisher portfolio.
Top 10 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 10 stock picks of Eli Casdin's Casdin Capital.
Top 10 Gainers on Friday
Sportswear retailer Foot Locker, Inc. (NYSE:FL), entertainment conglomerate Warner Bros. Discovery, Inc.
Top 10 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 10 stock picks of Eli Casdin's Casdin Capital.
10 Stocks Making Headlines Today
US equity market is in the red on Wednesday despite stronger-than-anticipated results from the US manufacturing sector.
Were Hedge Funds Right About Blueprint Medicines Corporation (BPMC)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Should I Avoid Blueprint Medicines Corporation (BPMC)?
A whopping number of 13F filings filed with U.S.
5 New Stock Picks of Billionaire Ken Fisher
In this article, we discuss the 5 new stock picks of billionaire Ken Fisher.
Eric Bannasch’s Cadian Capital Portfolio: 10 Biggest Stock Picks
In this article, we discuss the 10 biggest stock picks in Eric Bannasch's portfolio.
Blueprint Medicines Corporation (BPMC): Hedge Funds Are Snapping Up
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Should I Avoid Blueprint Medicines Corporation (BPMC)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is BPMC Stock A Buy or Sell?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US.
Is BPMC A Good Stock To Buy According To Hedge Funds?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Was The Smart Money Right About Loading Up On Blueprint Medicines Corporation (BPMC)?
Keeping this in mind, let's analyze whether Blueprint Medicines Corporation (NASDAQ:BPMC) is a good investment right now by following the lead of some of the best investors in...
5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
Marc Schneidman’s Aquilo Capital Management is a San Francisco-based, healthcare-focused long/short hedge fund that was founded in 2010.
Blueprint Medicines (BPMC): Hedge Fund Sentiment Reaches Another All Time High
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On Blueprint Medicines Corporation (BPMC) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Done Buying Blueprint Medicines Corporation (BPMC)
In this article we will take a look at whether hedge funds think Blueprint Medicines Corporation (NASDAQ:BPMC) is a good investment right now.
Hedge Funds Have Never Been This Bullish On Blueprint Medicines Corporation (BPMC)
We hate to say this but, we told you so.
How Did Blueprint Medicines Corporation (BPMC) Perform In Comparison to Hedge Fund Favorites in 2019?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Hedge Funds Love Medicines Corporation (BPMC) Way More Than These Stocks
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
